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Abstract 
 
Brucella melitensis is a severe pathogen for human and animals, even at low concentrations. The milk of sheep and 
goat and the fresh dairy products, including white cheese, are the main source of consumers’ contamination. Early 
detection, using reliable validated diagnostic tools, is crucial for the control and eradication of the disease. The aim of 
this study was to develop fast molecular in-house techniques, such as RT-qPCR, to detect Brucella genome in milk. The 
validation of the method was carried out according to the specifications of the Manual of Diagnostic Tests and 
Vaccines for Terrestrial Animals of the World Organization for Animal Health OIE in chapter 1.1.5: Validation and 
quality control of polymerase chain reaction methods used for diagnostic of infection disease and with the requests of 
the ISO/IEC 17025:2005: General requirements for the competence of testing and calibration laboratories. Tests for 
the RT-qPCR validation have proved his ability to detect 3.4 copies of Brucella's genome, into 5µl amplification 
product. Furthermore, DNA from non-Brucella microorganisms was not detected by developed method. While the 
identification of Brucella melitensis by traditional methods is time-consuming and may impair the outbreaks control, 
the RT-qPCR proposed can be used as a complementary, rapid and sensitive diagnostic tool for Brucella spp in 
Palestine, contributing to properly implement the control policy of authorities. 
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INTRODUCTION 
 
Brucellosis is a zoonotic disease and an 
important public health problem worldwide, 
especially in Mediterranean countries 
[Doganay et al., 2003; Gul et al., 2007]. 
The brucellosis is produced in different animal 
species by different Brucella species. The most 
significant and important, as zoonotic 
pathogen, in this genus is Brucella melitensis 
[Scholz et al., 2013; Mayer-Scholl et al., 2010]. 
Brucella infections are causing tremendous 
economic losses due to the decrease of the 
productivity as a result of abortion weakness of 
offspring and reduced milk production and may 
be associated with the loss of trade 
opportunities [FAO, 2010]. 
The human infections usually occur due to the 
ingestion of the contaminated dairy products or 
following the close contact with infected small 
ruminants [Saleem et al., 2010; Kaoud et al., 
2010; Doganay et al., 2003; Zvizdic et al., 
2006]. 
Milk of animals is the foremost source of 
humans’ infection with Brucella and its 
bacteriological isolation has low sensitivity 
(Ning et al., 2013), depending on the viability 
and number of Brucella in the sample, as well 
as the nature of the sample that is usually cross-
contaminated with various bacteria species. 
Thus, culture methods are not always 
successful, moreover, they are time-consuming 
and their handling could be hazardous [Hinic, 
2009; Refai et al., 2002]. 
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Serologic methods are rapid but inconclusive, 
because not all infected animals produce 
detectable levels of antibodies, and the cross-
reactivity against other antigens can give false-
positive results [Gwida et al., 2011]. Early 
detection of Brucella genome, by using valid 
diagnostic tools, is crucial for the control and 
eradication of this disease [Al-Garadi et al., 
2011; Bricker et al., 2002] The molecular 
diagnostic techniques represent an important 
breakthrough in the diagnostic practice. The 
most of the authors confirmed that real-time 
PCR is a highly sensitive method for the 
Brucella detection from various samples 
[Doosti et al., 2011; Safarpoor Denkordi et al. 
2014; Newby et al., 2003; Al-Garadi et al., 
2011; Mirnejad et al., 2012; Foster, 2008]. 
Laboratory tests for any infectious agent, by 
molecular diagnostic techniques, are requesting 
standardization, optimization and quality 
assurance [Sloan, 2007]. This is the request of 
the international quality standard for veterinary 
laboratories in Manual of Diagnostic Tests and 
Vaccines for Terrestrial Animals of the World 
Organization for Animal Health (OIE) chapter 
1.1.5: Validation and quality control of 
polymerase chain reaction methods used for 
diagnostic of infection disease and the guide 
ISO/IEC 17025:2005: General requirements for 
the competence of testing and calibration 
laboratory which demands for verification and 
validation procedures for each in-house assay 
(OIE, 2008; ISO/IEC 17025, 2005). 
The real time quantification is based on the 
relationship between initial template amount 
and Ct value, obtained during amplification, an 
optimal qPCR assay absolutely essential for 
accurate and reproducible quantification of 
samples.  
The hallmarks of an optimized qPCR assay are: 
linear standard curve (R2> 0,980 or r > 1- 
0.9901), high amplification efficiency 90-105% 
and consistency across replicate reactions [Bio 
Rad laboratories, 2006; Applied Biosystem, 
2003].  
The main objective of this study was to develop 
and validate an in-house Real-Time qPCR 
protocol, in order to provide a sensitive 
diagnostic tool for rapid detection of Brucella 
genome in sheep and goat milk. The most 
important epidemiological target was to 
implement a rapid preventive tool against 
brucellosis in Palestine. 
 
MATERIALS AND METHODS 
 
Samples preparation 
 
Control strains 
The reference control strains were: different 
non-Brucella bacteria used for optimization and 
validation RT-qPCR, were retrieved as loops 
from Oxoid Company; vaccine strain Brucella 
melitensis Rev 1 from Ovejero Company 
(Spain) and Brucella melitensis pure bacteria 
derived from our laboratory. 
In this study were also used wild Brucella 
melitensis strains and positive and negative 
milk samples (Table 2). All milk samples were 
obtained from animals during their lactation 
period: 10 ml of each milk sample was used for 
detection of Brucella genome by Real-Time 
PCR assay. 
 
Preparation of control reference strains 
Each reference strain of bacteria was inoculated 
onto specific nutrient agar. Plates were then 
incubated overnight at 37ºC under different 
specific condition, up to the requirements of 
each bacterium. After 24 hours each bacterium 
strain was confirmed by specific biochemical 
test; then few colonies were harvested from 
nutrient agar and immersed in 200 μl of 
phosphate buffer saline. From this, Brucella 
melitensis was inoculated on specific agar and 
harvested 48 hours later. 
 
DNA extraction 
All reference strains of non-Brucella and 
Brucella bacteria, B. melitensis Rev 1 vaccine 
strain, B. mellitensis wild strain, positive and 
negative milk samples, were extracted using a 
commercial kit QIAamp RNA Mini Kit 
(Qiagen, 52906) according to the 
manufacturer’s instructions. Before extraction 
milk samples were centrifuged at 8000 rpm for 
15 min to settle out the bacteria [Khan et al., 
2011; Romero et al., 1999]. The fatty top layer 
and supernatant were discarded and 200µl 
pellet were used for the extraction procedure. 
 
323
 
Determination of DNA concentration of 
Brucella melitensis Rev 1 vaccine 
In this study, for validation procedure and 
calculation was used Brucella melitensis Rev 1 
vaccines strain (Ovejero Company, Spain), as 
reference material. The DNA concentration was 
evaluated by using NanoDrop® ND-1000 Spec-
trophotometer Genomic (Thermo Scientific, 
USA). The concentration was given in ng/μl 
and then converted into gene copies per μl by 
using URI Genomics & Sequencing Center - 
dedicated software, created by Andrew 
Staroscik (2004). 
 
Validation of RT-qPCR 
Specificityand sensitivityof RT-qPCR 
Brucella spp. was identified using the primers 
and probe targeting the bcsp31 gene (GenBank 
accession number M20404) [Probert et al., 
2004]. The specificity of the primers and of the 
probes used in this study (Table 1) were 
analysed by using Standard Nucleotide BLAST 
(Basic Local Alignment Search Tool) adminis-
tered by the National Centre for Biotechnology 
Information (NCBI).The sensitivity and speci-
ficity of each qPCR assay were studied using 
different dilutions of DNA the Brucella 
melitensis Rev 1 and DNA the different non-
Brucella bacteria, positive and negative Brucella 
milk samples and negative control (Table 2). 
Table 1. Specific real-time PCR oligonucleotides primers 
and probe for Brucella group (Probert et al., 2004) 
PCR identification Primer sequence 5’Fluorophore/3’quencher 
Brucella spp F 5 –GCTCGGTTGCCAATATCAATGC-3 - 
Brucella spp R 5-  GGGTAAAGCGTCGCCAGAAG-3 - 
Brucella spp Probe 5-AAATCTTCCACCTTGCCCTTGCCATCA-3 6-FAM/BHQ1 
 
Limit of detection (LOD) and standard curve 
preparation 
The evaluation of LOD was performed by 
standard suspension of genomic DNA of 
Brucella melitensis Rev 1 vaccine strain, as 
initial stock, and 11 four-fold dilutions with 
three PCR replicates. Dilutions were chosen 
within the linear dynamic range of the assay 
and expected concentrations of DNA within 
possible specimens. Ct values were determined 
by running the RT-qPCR using 5μl of each 
dilution together with known standard PCR in 
the same run. The log-linear regression analysis, 
standard deviation and correlation coefficient of 
the Cq-values of each concentration was 
performed using Microsoft Excel 2007 software. 
Repeatability, reproducibility and efficiency of 
the test 
The efficiency of the RT-qPCR assays was 
evaluated in one run with 11 serial dilutions. 
The repeatability was evaluated by testing all 
dilutions in three replicates, in three PCR runs, 
and the assay was repeated in three different 
days. Tests of reproducibility were performed 
through running RT-qPCR protocol by another 
technician. The efficiency of the PCR was 
calculated from the slope of the logarithmic 
regression of Ct values plotted against DNA 
concentrations by E = e(−1/slope)−1. The effi-
ciency of the assay was then given by equation: 
E (100%) = (10-1/k – 1) x 100, where k is the 
slope of the standard curve obtained by linear 
regression with calculation y-intercept which 
corresponds Ct value for a single copy of the 
target molecule and coeficientul of determi-
nation (R2 ) such that 0 < r2 < 1, which denotes 
the strength of the linear association between x 
and y and represents the percent of the data that 
is the closest to the line of best fit and is a 
measure of how well the regression line repre-
sents the data [Eurogentec, 2013, Life techno-
logies, 2012, Bio-Rad laboratories, 2006]. 
 
Robustness and gel electrophoresis 
Robustness was evaluated by running all 
dilutions of Brucella melitensis Rev 1 strain on 
three different real time instruments: two 
instruments Real-Time PCR of SmartCycler® - 
Cepheid and LightCycler® - Roche. PCR 
products were analysed by 2% agarose 
(Promega, UK)gel electrophoresis. 
 
RESULTS AND DISCUSSIONS 
 
Concentration of DNA 
The concentration of genome stock Brucella 
melitensis Rev 1 vaccine was 2.5 ng/μl and 
equal to 3.52 x 106 copies of genomic DNA, 
considering the approximate size of Brucella 
genome 3290000000 bp [DelVecchio, 2002] 
and represents only one copy of the bcsp31 
gene on the Brucella genome. 
 
Evaluation specificity and sensitivity of RT-
qPCR 
The BLAST search showed that the primers 
and the probes did not have identity with other 
organisms. The primers sequences were 
324
 
identical 100% to their respective target. In 
order to perform the validation of RT-qPCR 
detection of the gene bcsp31 of Brucellaspp. 
were used: different dilutions of the vaccine 
strain Brucella melitensis Rev 1 as positive 
control and Brucella wild strains, and, as 
negative controls, negative milk samples and 
non-Brucella bacteria. Real time PCR was 
performed with a set of primers and probe 
showed in Table 1. DNA amplification mixture 
was composed of 7.12µl of nuclease free water, 
5 µl Qiagen 1 step RT PCR buffer x5 (Qiagen, 
Cat. No: 210212), 0.8µl dNTPs [200µM] 
(Qiagen, Ct. No: 210112), 0.5 µl forward and 
reverse primer [20µM/μl], 0.5 µl [5µM/μl] 
probe (Syntheza, Israel), 1µl Taq polymerase 
enzyme (Sigma, USA, Cat. No D4545) and 5µl 
of DNA product. Amplification was performed 
in SmartCycler, Cepheid. Reaction was 
initiated with denaturation at 95°C for 3 
minutes followed by 50 cycles: 95°C for 15 
sec, annealing and extension at 60°C for 35 
minutes. No amplification products were 
observed in real-time PCR of negative controls, 
whatever is the targets the non-Brucella micro-
organisms tested, Brucella melitensis negative 
milk or water samples [Table 2]. 
 
Limit of detection (LOD), preparation of 
standard curve and calculation of efficiency 
 
The stock suspension and 11 four-fold dilutions 
of template DNA Brucella melitensis Rev 1 
vaccine strain, ranging from 3.52x106 to 0.8 
gene copies per reaction indicate that 3.4 copies 
of bacterial genomes in 5μl of DNA the sample 
detected by developed RT-qPCR assay 
protocol. At these concentrations all Brucella 
positive bacteria and Brucella melitensis 
positive milk samples were positive. In this 
assay was calculated standard deviation and 
coefficient of variation [Table 3]. 
 
Table 2. Control and reference strains of bacteria used in validation of RT-qPCR and specificity evaluation result 
Strain Reference and origin Type of samples 
No of 
samples Results 
Brucella melitensis Rev 1  Elberg strain of vaccine, Ovejero Vaccine 2 Positive 
Brucella melitensis Field strain, our laboratory Pure bacteria 2 Positive 
Brucella melitensis positive milk samples Field strain, our laboratory Milk 10 Positive 
Bacillus cereus ATCC 11778, Oxoid Pure bacteria 2 Negative 
Campylobacter jejuni ATCC 29428, Oxoid Pure bacteria 2 Negative  
E.coli ATCC 12229, Oxoid Pure bacteria 2 Negative 
Salmonella enerica subsp Enteritidis ATCC 13076, Oxoid Pure bacteria 2 Negative 
Listeria monocytogenes ATCC 7644, Oxoid Pure bacteria 2 Negative 
Staphylococcus aureus ATCC 33862, Oxoid Pure bacteria 2 Negative 
Yersinia enterocolitica ATCC 23715, Oxoid Pure bacteria 2 Negative 
Brucella melitensis negative milk 
samples Our laboratory Milk 10 Negative 
Negative control  Water 2 Negative 
 
Table 3. DNA concentrations and Ct values, standard deviation and coefficient of correlation obtained from experiment 
 
No of dilution Concentration (ng/µl) 
No of copies in 1 
µl of RT-qPCR 
product 
No of genes copies 
in 5µl  
Ct  
Mean ± SD CV (%) 
Stock 2.5 704000  3.52x106 19.04 ± 0.07 0.003 
Dilution 1 0.625 176000  8.8 x 105 22.20 ±0.28 0.013 
Dilution 2 0.156 43900 2.2 x 105 24.37 ± 0.46 0.019 
Dilution 3 0.039 11000 5.5x104 26.72 ± 0.23 0.009 
Dilution 4 0.00975 2750  13750 29.52 ± 0.41 0.014 
Dilution 5 0.00244 687 3940 31.15 ± 0.26 0.008 
Dilution 6 0.000609 171 860 32.91 ± 0.23 0.007 
Dilution 7 0.000152 42.8 214 34.85 ± 0.68 0.019 
Dilution 8 0.0000380 10.7 53.5 36.21 ± 0.75 0.021 
Dilution 9 0.00000952 2.68 13.4 38.13 ± 0.09 0.002 
Dilution 10 0.00000238 0.67 3.4 39.04 ± 0.07 0.002 
Dilution 11 0.000000595 0.17 0.8 Not detect - 
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compromise DNA recovery from milk include 
difficulties in disrupting bacterial cell walls, 
loss of DNA template through extraction 
procedures, or the presence of potential 
polymerase inhibitors. In addition, the amount 
of milk used for PCR is much smaller than that 
required for bacteriological methods, and the 
number of organisms contained in a sample 
may thus not reach PCR detection limits 
[Yousef-Beingi, 2005]. For this purpose the 
milk samples were centrifuged and only 
concentrated bacteria (pellet) was used for 
extraction. 
Above of all these reasons, the quality of a 
laboratorial result is linked to the use of 
procedures such as validated methods, quality 
internal controls, participation in inter-
laboratorial comparison programs, the proper 
use of certified reference materials, and the 
compliance with requirements of standards. 
Some of the parameters used in validation such 
as the specificity and sensitivity of the method, 
the detection limit, linearity, the repeatability, 
the reproducibility, and the robustness, are 
crucial to produce reliable in-house method.  
In summary, we evaluated the feasibility of 
molecular assays as improved and very 
sensitive diagnostic tools for detection of 
Brucella spp. in fresh milk, especially during 
outbreaks. The advantages of this technique are 
that it can be performed very quickly, it allows 
the direct identification of the organism and it 
decrease the number of false-positive result 
[Soherbi et al., 2011; Redkar et al., 2001; 
Yousef-Beingi et al., 2009]. In addition, along 
with molecular assay, serology must always be 
performed and, in accord with the goal of the 
investigation, will be confirmed by bacterial 
isolation. 
 
CONCLUSIONS 
 
The RT-qPCR for the detection of Brucella 
spp. in fresh milk, above described, proved to 
be a sensitive and specific tool for the detection 
of Brucella genome.  
The efficiency of this assay was 96.5%, with y-
intercepts 18.7 and R2 value 0.09984.  
The proposed protocol is fast performed, it 
allows the direct identification of the organism 
and it increases the specificity of diagnostic. 
The critical step for our RT-qPCR is the 
quantity of the Brucella DNA in the milk 
samples: to reduce its impact, the milk samples 
have been centrifuged and the DNA extraction 
has been carried out only on the sediment 
bacteria (pellet). 
The novel molecular technique such as RT-
qPCR in-house is cost-efficiency affordable 
and is useful as a reliable screening method for 
the rapid detection of the infectious agent: the 
use of this technique could be a huge step in 
order to rapidly implement the measures for the 
outbreak control, to prevent spread of the 
disease and to avoid the human infections. This 
method is designed to be performed using raw 
milk. 
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